SPONSOR: Sen. Paradee & Rep. Lynn Sens. Sokola, Wilson; Reps. Hilovsky, K. Johnson, Ross Levin DELAWARE STATE SENATE 153rd GENERAL ASSEMBLY SENATE CONCURRENT RESOLUTION NO. 52 RECOGNIZING FEBRUARY 15, 2025, AS ANGELMAN SYNDROME AWARENESS DAY IN THE STATE OF DELAWARE.
SPONSOR: Sen. Paradee & Rep. Lynn Sens. Sokola, Wilson; Reps. Hilovsky, K. Johnson, Ross Levin
SPONSOR: Sen. Paradee & Rep. Lynn
Sens. Sokola, Wilson; Reps. Hilovsky, K. Johnson, Ross Levin
SPONSOR:
Sen. Paradee & Rep. Lynn
Sens. Sokola, Wilson; Reps. Hilovsky, K. Johnson, Ross Levin
DELAWARE STATE SENATE
153rd GENERAL ASSEMBLY
SENATE CONCURRENT RESOLUTION NO. 52
RECOGNIZING FEBRUARY 15, 2025, AS ANGELMAN SYNDROME AWARENESS DAY IN THE STATE OF DELAWARE.
WHEREAS, Angelman syndrome is a rare neuro-genetic disorder that occurs in one in 15,000 live births and affects approximately 500,000 individuals worldwide; and WHEREAS, Angelman syndrome is caused by a loss of function of the UBE3A gene in the 15 th chromosome derived from the mother, and which is needed to develop and control speech and movement; and WHEREAS, individuals with Angelman syndrome begin experiencing developmental delays starting between 6 and 12 months, and these developmental delays are often the first signs of Angelman syndrome; and WHEREAS, in addition to delayed development, Angelman syndrome causes problems with speech and balance, mental disability, and, sometimes, seizures; and WHEREAS, Angelman syndrome shares symptoms and characteristics with other disorders, including autism, cerebral palsy, and Prader-Willi syndrome, and WHEREAS, individuals with Angelman syndrome have an overall happy and excitable demeanor, and they smile and laugh often; and WHEREAS, Angelman syndrome is rare; most individuals with Angelman syndrome do not have a family history of the syndrome, and researchers often do not know what causes the genetic changes that result in the disease; and WHEREAS, Angelman syndrome can lead to several complications, including trouble feeding, hyperactivity, sleep troubles, scoliosis, and obesity; and WHEREAS, the treatment of Angelman syndrome focuses on managing medical, sleep, and developmental issues; and WHEREAS, there is currently no cure for Angelman syndrome, but organizations, such as the Angelman Syndrome Foundation, note that, with further research, there may be a cure in the future; and WHEREAS, organizations worldwide recognize February 15 th as International Angelman Day to raise awareness about Angelman syndrome. NOW, THEREFORE: BE IT RESOLVED by the Senate of 153 rd General Assembly of the State of Delaware, the House of Representatives concurring therein, that February 15, 2025, is recognized as Angelman Syndrome Awareness Day. BE IT FURTHER RESOLVED that the General Assembly affirms the importance of raising awareness of Angelman syndrome to ensure effective screening, diagnosis, and treatment of the disease.
WHEREAS, Angelman syndrome is a rare neuro-genetic disorder that occurs in one in 15,000 live births and affects approximately 500,000 individuals worldwide; and
WHEREAS, Angelman syndrome is caused by a loss of function of the UBE3A gene in the 15 th chromosome derived from the mother, and which is needed to develop and control speech and movement; and
WHEREAS, individuals with Angelman syndrome begin experiencing developmental delays starting between 6 and 12 months, and these developmental delays are often the first signs of Angelman syndrome; and
WHEREAS, in addition to delayed development, Angelman syndrome causes problems with speech and balance, mental disability, and, sometimes, seizures; and
WHEREAS, Angelman syndrome shares symptoms and characteristics with other disorders, including autism, cerebral palsy, and Prader-Willi syndrome, and
WHEREAS, individuals with Angelman syndrome have an overall happy and excitable demeanor, and they smile and laugh often; and
WHEREAS, Angelman syndrome is rare; most individuals with Angelman syndrome do not have a family history of the syndrome, and researchers often do not know what causes the genetic changes that result in the disease; and
WHEREAS, Angelman syndrome can lead to several complications, including trouble feeding, hyperactivity, sleep troubles, scoliosis, and obesity; and
WHEREAS, the treatment of Angelman syndrome focuses on managing medical, sleep, and developmental issues; and
WHEREAS, there is currently no cure for Angelman syndrome, but organizations, such as the Angelman Syndrome Foundation, note that, with further research, there may be a cure in the future; and
WHEREAS, organizations worldwide recognize February 15 th as International Angelman Day to raise awareness about Angelman syndrome.
NOW, THEREFORE:
BE IT RESOLVED by the Senate of 153 rd General Assembly of the State of Delaware, the House of Representatives concurring therein, that February 15, 2025, is recognized as Angelman Syndrome Awareness Day.
BE IT FURTHER RESOLVED that the General Assembly affirms the importance of raising awareness of Angelman syndrome to ensure effective screening, diagnosis, and treatment of the disease.
SYNOPSIS This concurrent resolution recognizes February 15, 2025, as Angelman Syndrome Awareness Day in the State of Delaware. Author: Senator Paradee
SYNOPSIS
This concurrent resolution recognizes February 15, 2025, as Angelman Syndrome Awareness Day in the State of Delaware.
Author: Senator Paradee